Astellas Pharma (STU:YPH) Other Operating Expense : €1,645 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Astellas Pharma Other Operating Expense?

Astellas Pharma's Other Operating Expense for the three months ended in Mar. 2024 was €714 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €1,645 Mil.

Astellas Pharma's quarterly Other Operating Expense declined from Sep. 2023 (€408 Mil) to Dec. 2023 (€339 Mil) but then increased from Dec. 2023 (€339 Mil) to Mar. 2024 (€714 Mil).

Astellas Pharma's annual Other Operating Expense increased from Mar. 2022 (€899 Mil) to Mar. 2023 (€1,344 Mil) and increased from Mar. 2023 (€1,344 Mil) to Mar. 2024 (€1,584 Mil).

Astellas Pharma Other Operating Expense Historical Data

The historical data trend for Astellas Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma Other Operating Expense Chart

Astellas Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

461.72

1,074.83

898.53

1,343.79

1,583.97

Astellas Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															773.86	184.22	407.64	339.34	713.98

Astellas Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,645 Mil.

Astellas Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Astellas Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Astellas Pharma (STU:YPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (STU:YPH) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

ALPMY:USA ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Astellas Pharma (STU:YPH) Headlines

No Headlines